ANA MARIA
GONZALEZ PINTO ARRILLAGA
PROFESORADO CATEDRATICO/A DE UNIVERSIDAD
Universidad de Alcalá
Alcalá de Henares, EspañaPublicaciones en colaboración con investigadoras/es de Universidad de Alcalá (27)
2024
-
Areas of interest and sentiment analysis towards second generation antipsychotics, lithium and mood stabilizing anticonvulsants: Unsupervised analysis using Twitter
Journal of Affective Disorders, Vol. 351, pp. 649-660
-
Health service and psychotropic medication use for mental health conditions among healthcare workers active during the Spain Covid-19 Pandemic – A prospective cohort study using web-based surveys.
Psychiatry Research, Vol. 334
2023
-
Effect of mindfulness-based cognitive therapy vs. psychoeducational intervention on plasma brain-derived neurotrophic factor and cognitive function in bipolar patients: a randomized controlled trial
Frontiers in Psychiatry, Vol. 14
-
Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort
Psychiatry Research, Vol. 325
-
The polygenic basis of relapse after a first episode of schizophrenia
European Neuropsychopharmacology, Vol. 75, pp. 80-92
-
Traumatic stress symptoms among Spanish healthcare workers during the COVID-19 pandemic: a prospective study
Epidemiology and psychiatric sciences, Vol. 32, pp. e50
2022
-
Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic
Journal of Psychiatric Research, Vol. 149, pp. 10-17
-
Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort
Schizophrenia Research, Vol. 244, pp. 101-110
2021
-
Mindfulness-based cognitive therapy versus psychoeducational intervention in bipolar outpatients: Results from a randomized controlled trial
Revista de Psiquiatria y Salud Mental
-
The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design
Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 164-176
2020
-
Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis Cohort
Schizophrenia bulletin, Vol. 46, Núm. 4, pp. 1019-1025
-
Needs of people with psychosis and their caregivers: «In their own voice»
Revista de Psiquiatria y Salud Mental, Vol. 13, Núm. 2, pp. 80-89
-
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort
Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552
2019
-
CIBERSAM: Ten years of collaborative translational research in mental disorders
Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8
2018
-
Smoking does not impact social and non-social cognition in patients with first episode psychosis
Schizophrenia Research, Vol. 199, pp. 64-74
2017
-
Cannabis use, COMT, BDNF and age at first-episode psychosis
Psychiatry Research, Vol. 250, pp. 38-43
-
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients
European Neuropsychopharmacology, Vol. 27, Núm. 7, pp. 647-656
-
Modelling gene-environment interaction in first episodes of psychosis
Schizophrenia Research, Vol. 189, pp. 181-189
-
Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset
Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422
2016
-
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4